Kaplan Thaler’s DuFour Heads to DDB

NEW YORK Nannette LaFond-DuFour, who ran the Pfizer business at Publicis Groupe’s The Kaplan Thaler Group, has left that agency for an account management position at Omnicom Group’s DDB, sources said.

Neither her start date at DDB in New York nor which account she will work on could be determined, but sources said DuFour would report to DDB New York managing director Peter Hempel. DuFour’s last day at Kaplan Thaler in New York was Friday, sources said.

A representative for DDB New York declined to comment on DuFour.

DuFour joined Kaplan Thaler in October 2003 as group account director. The agency handles Pfizer’s Zoloft and Celebrex. Before that, she ran Pfizer’s Relpax account at sibling agency Publicis in New York.

DuFour could not be reached for comment, nor could a representative for Kaplan Thaler.